McKesson Corporation Reports Fiscal 2025 Second Quarter Results and Raises Full Year Adjusted EPS Guidance
McKesson Corporation (NYSE: MCK) has released its fiscal 2025 second quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.
McKesson's Fiscal Q2 EPS Tops Forecast
McKesson's earnings for its fiscal 2025 second quarter exceeded expectations, despite special charges that cut into net income.
MCK Stock Gains as Q2 Earnings & Sales Top Estimates, '25 EPS View Up
McKesson Corporation MCK reported second-quarter fiscal 2025 adjusted earnings per share (EPS) of $7.07, which beat the Zacks Consensus Estimate of $6.89 by 2.6%. The bottom line also improved 13.5% on a year-over-year basis.
McKesson Corporation Reports Strong Q2 Earnings Growth
McKesson Corporation ( (MCK) ) has released its Q2 earnings. Here is a breakdown of the information McKesson Corporation presented to its
McKesson: Fiscal Q2 Earnings Snapshot
(MCK) on Wednesday reported fiscal second-quarter net income of $241 million. The Irving, Texas-based company said it had net income of $1.87 per share. Earnings, adjusted for one-time gains and costs,
McKesson (MCK) Q2 Earnings and Revenues Beat Estimates
McKesson (MCK) came out with quarterly earnings of $7.07 per share, beating the Zacks Consensus Estimate of $6.89 per share. This compares to earnings of $6.23 per share a year ago. These figures are adjusted for non-recurring items.
McKesson raises annual profit forecast on strength in its U.S. pharma segment
Drug distributor McKesson Corp raised its annual profit forecast on Wednesday, driven by increased sales in its U.S.
McKesson will pay $448,000 for hiring bias against Black, Hispanic and white applicants
An arm of health care giant McKesson will pay $448,578 in back wages and interest as part of an agreement with the U.S.
Is McKesson Corporation (MCK) the Best Pharma Stock to Buy Right Now?
We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...
Nasdaq3d
Should You Buy, Sell or Hold McKesson Before Q2 Earnings?
McKesson Corporation MCK is scheduled to report second-quarter fiscal 2025 results on Nov. 6, after market close. The company delivered an earnings surprise of 10.06% in the last reported quarter.
McKesson’s Strong Q2 Performance Leads to Upward EPS Revision, But Hold Rating Due to Segment Concerns and Uncertain Long-Term Growth
Steve Baxter, an analyst from Wells Fargo, maintained the Hold rating on McKesson (MCK – Research Report). The associated price target ...
This McKesson Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, ...